account_id none on file
legal_name Arrowhead Pharmaceuticals, Inc.
ticker ARWR
cik 879407
domain arrowheadpharma.com
linkedin_company_url https://www.linkedin.com/company/arrowhead-pharmaceuticals
entry_point_account_id none on file
name Arrowhead Pharmaceuticals Inc.
exchange Nasdaq
sector Health Care
hq Pasadena, CA, United States
sector index/company/sector/health-care/
calls 1 filings 0 executives 4 family 0
why_nownone on file
calls
As we discussed in our last conference call, Arrowhead has reached a point where our business requires a greater degree of focus. We are in the process of building out our expertise within the cardiometabolic space and focusing more of our spend in that area.
May 9, 2024 / receipt, needs a key / Dr. Chris Anzalone, CEO | earnings call 2024-05-09 | transcript a8bb166d-30de-4644-b254-597ab0b3d85d | chars 2163-2422 | segment 2
filingsnone on file
executives
| Douglas Ingram | director | - | receipt |
| Dr. Bruce Gibbon | Interim Chief Medical Scientist | - | receipt |
| Dr. Chris Anzalone | CEO | - | receipt |
| Patrick O’Brien | Chief Operating Officer | - | receipt |
familynone on file
upcoming
| 2026-11-24 | earnings call | scheduled | ir |
changes
| 2025-02-07 | director, appointed | sec_8k |
| 2022-07-20 | Chief Operating Officer, appointed | sec_8k |
| 2011-02-03 | Vice President, departed | sec_8k |
mcp_package_hint
slug arrowhead-pharmaceuticals-inc
listing_url https://steadybase.io/company/data/index.json
mcp_url https://mcp.steadybase.io/mcp
steadybase-$